Compare ARK Genomic Revolution ETF (ARKG) vs Blackstone Inc (BX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Blackstone Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Blackstone Inc trades at $123.33 (market cap $150.36B). The key difference: Blackstone Inc pays a 4.04% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Blackstone Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | BX | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $43.57 | $188.68 |
52-Week Low | $23.09 | $102.12 |
Market Cap | — | $150.36B |
Dividend Yield | — | 4.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Blackstone (BX) trades at $123.08, up 0.78% with a bullish technical signal. The stock shows strong fundamentals with revenue growth to $12.41B in 2025 and consistent earnings beats. Recent news highlights strategic moves in data centers and private equity, while analyst consensus is strongly bullish with a $147.44 price target.
Outlook remains positive driven by earnings momentum and strategic investments, though risks include market volatility and execution challenges. The current valuation at 31.56 P/E suggests premium pricing, requiring sustained growth to justify upside potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Blackstone Inc
Blackstone is one of the world's largest alternative asset managers with $940.8 billion in total asset under management, including $683.8 billion in fee-earning asset under management, at the end of June 2022.
Read more on BX →
